Macular infarction after intravitreal injection of amikacin: Case report;Maculopatia isquêmica após injeção intravítrea de amicacina: Relato de caso

Arquivos Brasileiros de Oftalmologia

Volumn 68, Issue 6, 2005, Pages 837-840

  de Almeida, Luciana Negrão Frota ^a,b   da Rocha Canêdo, Miguel Gustavo Rosa ^a   de Almeida, Rafael Negrão Frota ^c   de Almeida Sobrinho, Edmundo Frota ^c   Nehemy, Márcio Bittar ^d  

^a Fundacao Banco de Olhos de Goias   (Brazil)

^b Universidade Federal do Pará ^*  (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Amikacin adverse effects; Amikacin therapeutic use; Aminoglycosides therapeutic use; Case report publication type ; Endophthalmitis; Injections; Intravenous; Macular degeneration etiology; Postoperative complications; Vancomycin therapeutic use; Visual acuity

Indexed keywords

ACETAZOLAMIDE; AMIKACIN; AZITHROMYCIN; DEXAMETHASONE; GENTAMICIN; PARACETAMOL; VANCOMYCIN;

ADULT; ARTICLE; CASE REPORT; CATARACT EXTRACTION; DRUG DOSE REGIMEN; ENDOPHTHALMITIS; FEMALE; HUMAN; LENS IMPLANT; POSTOPERATIVE COMPLICATION; RETINA BLOOD VESSEL OCCLUSION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 33746373907     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/s0004-27492005000600023     Document Type: Article

References (14)

1. Results of the Endophthalmitis Vitrectomy Study. A randomized of immediate vitrectomy and of intravenous antibiotics for treatment of postoperative endophthalmatis. Arch Ophthalmol. 1995;113(12):1479-96.
2. Donahue SP, Kowalski RP, Jewart H, Friberg TR. Vitreous cultures in suspected endophthalmitis. Biopsy or vitractomy? Ophthalmology. 1993; 100(4):452-55.
3. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol.1996;122(1):1-17. Erratum in: Am J Ophthalmol. 1996;122(6):920.
4. Campochiaro PA, Conway BP. Aminoglycoside toxicity - a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol. 1991;109(7):946-50.
5. D' Amico DJ, Caspers-Velu VL, Libert J, Shanks E, Schrooyen M, Hanninen LA, et al. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am J Ophthalmol. 1985;100(2):264-75.
6. Campochiaro PA, Lim JI. Aminoglycoside toxicity in the treatment of endophthalmitis. The Aminoglycoside Toxicity Group. Arch Ophthalmol. 1994;112(1):48-53.
7. Galloway G, Ramsay A, Jordan K, Vivian A. Macular infarction after intravitreal amikacin: mountig evidence against amikacin. Br J Ophthalmol. 2002; 86(3):359-60.
8. Yen S, Branco BC, Yasaki ES, Schor P, Freitas D, Belfor Junior R. Minimizando erros na administração de drogas intravítreas. Arq Bras Oftalmol. 2003; 66(2):125-8.
9. Smiddy WE, Flynn Jr HW. Posterior segment complications of anterior segment surgery. In: Regillo CD, Brown GC, Flynn Jr HW. Vitreoretinal disease the essentials. New York: Thieme: 1999.
10. Verma L, Arora R, Sachdev MS. Macular infarction after intravitreal injection of amikacin. Can J Ophthalmol. 1993;28(5):241-3.
11. Oum BS, D'Amico DJ, Wong KW. Intravitreal antibiotic therapy with vancomycin and aminoglycoside: an experimental study of combination and repetitive injections. Arch Ophthalmol. 1989;107(7):1055-60.
12. Farah ALH, Farah ME, Moreira Junior CA. Endoftalmite exógena. In: Abujamra S, Ávila M, Barsante C, Farah ME, Gonçalves JOR, Lavinsky J, et al. Retina e vítreo: clínica e cirurgia. São Paulo: Roca; 2000. p.716-27.
13. Molinari LC. Endoftalmites: aspectos profiláticos e terapêuticos. Rev Bras. Oftalmol. 1995;54(5):37-43.
14. Campochiaro PA, Green WR. Toxicity intravitreous ceftazidime in primate retina. Arch Opthalmol. 1992;110(11):1625-9.